To include your compound in the COVID-19 Resource Center, submit it here.

FDA panel recommends some doses of CAM2038

A joint meeting of FDA's Psychopharmacologic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee recommended approval of some doses of CAM2038 from Braeburn

Read the full 260 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE